Baseline demographics and clinical characteristics of the study cohort
| Variables | Alcohol-associated hepatitis (n=5) | Alcohol-associated cirrhosis (n=5) |
| Age (years) | 40.8±7.7 | 58.2±6.3 |
| Sex | 3M/2F | 3M/2F |
| White cell count (×109/L) | 13.8±7.05 | 4.5±1.1 |
| Hemoglobin (g/dL) | 7.7±0.4 | 10.2±1.4 |
| Platelet count (×109/L) | 83.2±48.7 | 90±65.7 |
| Total bilirubin (mg/dL) | 32.4±12.6 | 2.6±0.8 |
| AST (U/L) | 125.6±19.5 | 52.2±25.3 |
| ALT(U/L) | 52.4±13.8 | 27.6±16.8 |
| Alkaline phosphatase (U/L) | 137.8±42.8 | 133.4±30.5 |
| Albumin (g/dL) | 3.34±0.49 | 3.0±0.3 |
| Creatinine (mg/dL) | 1.64±0.76 | 1.1±0.4 |
| MELD score | 37.4±4.6 | 15.2±3.1 |
ALT, alanine aminotransferase; AST, aspartate aminotransferase; F, female; M, male; MELD, model for end stage liver disease.